Ilsung Pharm (003120) — Cash Flow Reinvestment Rate
Ilsung Pharm (003120) has a Cash Flow Reinvestment Rate of 0.56x as of June 2025, reinvesting ₩2.89 Billion (capex ₩395.62 Million plus investments ₩-2.50 Billion) from operating cash flow of ₩5.13 Billion. See how much free cash does Ilsung Pharm generate to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Ilsung Pharm Cash Flow Reinvestment Rate (2013–2025)
Historical reinvestment intensity for Ilsung Pharm across 9 annual periods. For the full cash flow conversion analysis, see Ilsung Pharm operating cash flow efficiency.
Annual Cash Flow Reinvestment Rate for Ilsung Pharm (2013–2025)
Year-by-year capital reinvestment analysis for Ilsung Pharm. See Ilsung Pharm financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.26x | ₩8.79 Billion | ₩3.88 Billion | ₩2.18 Billion | ▼ -59.9% |
| 2021 | 5.65x | ₩32.21 Billion | ₩5.70 Billion | ₩10.93 Billion | ▲ +25.1% |
| 2020 | 4.52x | ₩7.03 Billion | ₩1.56 Billion | ₩4.82 Billion | ▼ -11.7% |
| 2019 | 5.11x | ₩22.44 Billion | ₩4.39 Billion | ₩1.24 Billion | ▲ +540.5% |
| 2018 | 0.80x | ₩12.05 Billion | ₩15.09 Billion | ₩1.21 Billion | ▲ +96.7% |
| 2017 | 0.41x | ₩4.12 Billion | ₩10.16 Billion | ₩1.85 Billion | ▼ -58.5% |
| 2015 | 0.98x | ₩5.91 Billion | ₩6.04 Billion | ₩2.85 Billion | ▼ -37.6% |
| 2014 | 1.57x | ₩6.57 Billion | ₩4.19 Billion | ₩945.31 Million | ▲ +222.5% |
| 2013 | 0.49x | ₩2.46 Billion | ₩5.06 Billion | ₩1.13 Billion | — |